Riskpilot← Back to searchSign inGet full accessENGVET INVEST ApS
APSActiveCVR 35413081Gadeledsvej 27COther financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 20132 employees
Revenue 2025
DKK 273K
+2696% vs 2024
EBITDA margin
4.7%
+116% vs 2024
Equity ratio
3.7%
Financial strength
Net profit 2025
DKK 94K
+4431% vs 2024
| Revenue | DKK 273K | +2696% |
| EBITDA | DKK 13K | +116% |
| Net profit | DKK 94K | +4431% |
| Total assets | DKK 7,3M | +15% |
| Equity | DKK 273K | +52% |
| Employees | 2 | — |
Legal name
ENGVET INVEST ApS
CVR number
35413081
Legal form
Anpartsselskab
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
10. august 2013
Share capital
DKK 100.000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør.
Company purpose
Selskabets formål er investering i mindre selskaber, administration af selskaber og handle med levnedsmidler, helseprodukter og kosmetik samt aktiviteter beslægtet dermed.
Address
Gadeledsvej 27C
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | -25 | 412 | 10 | 273 |
| Staff expenses | -58 | -99 | -425 | -89 | -261 |
| EBITDA | -58 | -125 | -13 | -80 | 13 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -58 | -125 | -13 | -80 | 13 |
| Net financials | -985 | 66 | 65 | 77 | -22 |
| Profit before tax | -1.043 | -58 | 52 | -3 | 120 |
| Tax | -9 | 8 | 12 | -1 | 26 |
| Net profit | -1.034 | -66 | 41 | -2 | 94 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3.274 | 3.627 | 5.078 | 6.366 | 7.333 |
| Equity | 207 | 141 | 181 | 179 | 273 |
| Long-term debt | 2.946 | 3.246 | 4.576 | 5.806 | 6.446 |
| Short-term debt | 121 | 241 | 321 | 381 | 614 |
| Total debt | 3.067 | 3.487 | 4.897 | 6.187 | 7.060 |
EBITDA margin
4.7%
This company
15.8%
Market median
-70% vs market
20212025
Equity ratio
3.7%
This company
38.2%
Market median
-90% vs market
20212025
Return on equity
34.3%
This company
18.4%
Market median
+86% vs market
20212025
Net profit margin
34.2%
This company
8.1%
Market median
+322% vs market
20212025
Asset turnover
0.04×
This company
1.12×
Market median
-96% vs market
20212025
Debt / equity
25.88×
This company
0.62×
Market median
-4074% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
CE Chief Executive Officer | Chief Executive Officer | 2014 |
JE Management | Management | 2021 |
| Former (1) | ||
MG Management | Management | 2014 – 2017 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 66.67–89.99% | 66.67–89.99% | 2020 | |
| Individual | 10–14.99% | 10–14.99% | 2020 | |
| Individual | 10–14.99% | 10–14.99% | 2020 | |
| Individual | 10–14.99% | 10–14.99% | 2020 | |
| Individual | 66.67–89.99% | 66.67–89.99% | 2013 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ENGVET INVEST ApS 
PRO DEVICES A/SBoard members of ENGVET INVEST ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Charlotte Enghave Fruergaard | Chief Executive Officer | 0 companies |
| Jesper Enghave Fruergaard | Management | 0 companies |
| Martin Georg Reuter | Management | 0 companies |